Thalidomide-O-C10-NH2 is primarily utilized in research and development within the pharmaceutical industry, particularly in the study of immunomodulatory and anti-inflammatory agents. Its structure allows it to interact with specific biological targets, making it a candidate for investigating potential treatments for conditions such as cancer, autoimmune diseases, and chronic inflammatory disorders. Researchers explore its ability to inhibit angiogenesis, which is crucial in halting the growth of tumors. Additionally, it is studied for its potential role in modulating cytokine production and enhancing the efficacy of other therapeutic agents. Its application is largely confined to preclinical studies, where it serves as a valuable tool for understanding molecular mechanisms and developing novel drug candidates.